Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Aug;80(8):773–774. doi: 10.1136/bjo.80.8.773

Acanthamoeba keratitis: risk factors and outcome.

J Hay, D V Seal
PMCID: PMC505602  PMID: 8949730

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacon A. S., Frazer D. G., Dart J. K., Matheson M., Ficker L. A., Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond) 1993;7(Pt 6):719–725. doi: 10.1038/eye.1993.168. [DOI] [PubMed] [Google Scholar]
  2. Bottone E. J., Madayag R. M., Qureshi M. N. Acanthamoeba keratitis: synergy between amebic and bacterial cocontaminants in contact lens care systems as a prelude to infection. J Clin Microbiol. 1992 Sep;30(9):2447–2450. doi: 10.1128/jcm.30.9.2447-2450.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elder M. J., Dart J. K. Chemotherapy for acanthamoeba keratitis. Lancet. 1995 Mar 25;345(8952):791–793. doi: 10.1016/s0140-6736(95)90670-3. [DOI] [PubMed] [Google Scholar]
  4. Elder M. J., Kilvington S., Dart J. K. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1059–1064. [PubMed] [Google Scholar]
  5. Green K., Livingston V., Bowman K., Hull D. S. Chlorhexidine effects on corneal epithelium and endothelium. Arch Ophthalmol. 1980 Jul;98(7):1273–1278. doi: 10.1001/archopht.1980.01020040125020. [DOI] [PubMed] [Google Scholar]
  6. Hay J., Kirkness C. M., Seal D. V., Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye (Lond) 1994;8(Pt 5):555–563. doi: 10.1038/eye.1994.137. [DOI] [PubMed] [Google Scholar]
  7. Illingworth C. D., Cook S. D., Karabatsas C. H., Easty D. L. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol. 1995 Dec;79(12):1078–1082. doi: 10.1136/bjo.79.12.1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Larkin D. F., Kilvington S., Dart J. K. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992 Feb;99(2):185–191. doi: 10.1016/s0161-6420(92)31994-3. [DOI] [PubMed] [Google Scholar]
  9. Larkin D. F., Kilvington S., Dart J. K. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992 Feb;99(2):185–191. doi: 10.1016/s0161-6420(92)31994-3. [DOI] [PubMed] [Google Scholar]
  10. Marrie T. J., Costerton J. W. Prolonged survival of Serratia marcescens in chlorhexidine. Appl Environ Microbiol. 1981 Dec;42(6):1093–1102. doi: 10.1128/aem.42.6.1093-1102.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Seal D. V., Hay J., Kirkness C. M. Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. Lancet. 1995 Jan 14;345(8942):136–136. doi: 10.1016/s0140-6736(95)90106-x. [DOI] [PubMed] [Google Scholar]
  12. Stickler D. J., Thomas B. Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection. J Clin Pathol. 1980 Mar;33(3):288–296. doi: 10.1136/jcp.33.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES